The oral presentation by Dr Kim O’Sullivan from Monash University in Melbourne will be held during
the plenary session on 8 April 2024 at 9:30am (CET time), and will examine recent pre-clinical studies
that demonstrate the potential to ameliorate the underlying processes associated with autoimmune
diseases such as ANCA vasculitis.
Ann: Presentation to highlight broader potential of Deoxymabs, page-76
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.001(8.33%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $7.685K | 1.149M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 5861931 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 1961506 | 5 |
View Market Depth
| Last trade - 11.55am 12/09/2024 (20 minute delay) ? |
| PAB (ASX) Chart |